ArticleThe New England journal of medicine2019
Immune Checkpoint Blockade plus Axitinib for Renal-Cell Carcinoma. Reply.
Robert J Motzer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleThe New England journal of medicine2019
Robert J Motzer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.